ArticleFrontiers in pharmacology2023

Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance.

Ryunha Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.